Platelet-activating factor (PAF) acetylhydrolase activity, LIS1 expression, and seizures

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Lissencephaly is a severe brain malformation characterized by recurrent seizures.
• The LIS1 gene, implicated in lissencephaly, encodes a subunit of platelet-activating factor acetylhydrolase (PAF-AH) and influences microtubule dynamics.
• The molecular mechanisms linking LIS1 dysfunction to seizures require further elucidation.

Purpose of the Study:

• To investigate the molecular involvement of LIS1 in seizure pathogenesis.
• To establish a correlation between LIS1 expression, PAF-AH activity, and seizure events in a rat model.

Main Methods:

• Kainate-induced seizures were modeled in rats.
• Platelet-activating factor acetylhydrolase (PAF-AH) enzymatic activity was measured.
• LIS1 and its alpha2 catalytic subunit expression levels were analyzed in the dentate gyrus.
• Microtubule-associated fractions were examined for LIS1 isoforms.

Main Results:

• PAF-AH activity significantly decreased within 30 minutes of seizure induction, serving as a sensitive seizure indicator.
• LIS1 expression in the dentate gyrus mirrored PAF-AH activity changes.
• A novel, higher-mobility LIS1 isoform, enriched in microtubules, was detected post-seizure.
• Expression of the alpha2 catalytic subunit of PAF-AH was dramatically altered.

Conclusions:

• LIS1 expression is a critical regulator of PAF-AH activity.
• Reduced LIS1 levels in lissencephaly patients may increase seizure susceptibility.
• The identified LIS1 isoform may play a role in the cellular response to seizures.